| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 4,147 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 4,147 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 3,789 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 3,789 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 15,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 15,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 20,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 20,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 43,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 43,000 | — | — |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 2,717,627 | $124.00 | $337.0M? |
| Nuvalent, Inc. | NUVL | James E. FlynnDirDERIVJOINT | Jul 15 | D | 2,717,627 | $124.00 | $337.0M? |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | D | 3,444 | $124.00 | $427K |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | U | 5,146 | $124.00 | $638K |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | U | 5,146 | $124.00 | $638K |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | D | 650,000 | $124.00 | $80.6M |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | D | 8,299,225 | $124.00 | $1.0B? |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jul 15 | D | 8,299,225 | $124.00 | $1.0B? |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Jun 16 | A | 3,444 | $0.00 | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 464,550 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 464,550 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 246,732 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 246,732 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 143,650 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 143,650 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 166,070 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%DERIVJOINT | Jun 11 | C | 166,070 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 407,132 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 407,132 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 260,992 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 260,992 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 149,238 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 149,238 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 122,990 | — | — |
| Parabilis Medicines, Inc. | PBLS | James E. Flynn10%JOINT | Jun 11 | C | 122,990 | — | — |
| Larimar Therapeutics, Inc. | LRMR | James E. FlynnDirDERIVJOINT | May 19 | A | 55,150 | $0.00 | —? |
| Larimar Therapeutics, Inc. | LRMR | James E. FlynnDirJOINT | Feb 27 | P | 2,000,000 | $5.00 | $10.0M |
| Larimar Therapeutics, Inc. | LRMR | James E. FlynnDirJOINT | Feb 27 | P | 831,978 | $5.00 | $4.2M |
| Larimar Therapeutics, Inc. | LRMR | James E. FlynnDirJOINT | Feb 27 | P | 1,084,012 | $5.00 | $5.4M |
| Larimar Therapeutics, Inc. | LRMR | James E. FlynnDirJOINT | Feb 27 | P | 1,084,010 | $5.00 | $5.4M |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Nov 24 | S | 371,287 | $95.45 | $35.4M |
| Nuvalent, Inc. | NUVL | James E. FlynnDirJOINT | Nov 24 | S | 371,287 | $95.45 | $35.4M |